vs

Side-by-side financial comparison of Dexcom (DXCM) and Roblox Corp (RBLX). Click either name above to swap in a different company.

Roblox Corp is the larger business by last-quarter revenue ($1.4B vs $1.3B, roughly 1.1× Dexcom). Dexcom runs the higher net margin — 21.2% vs -22.3%, a 43.6% gap on every dollar of revenue. On growth, Roblox Corp posted the faster year-over-year revenue change (43.2% vs 21.6%). Over the past eight quarters, Roblox Corp's revenue compounded faster (32.9% CAGR vs 12.0%).

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.

Roblox Corporation is an American video game developer based in San Mateo, California. Founded in 2004 by David Baszucki and Erik Cassel, the company is the developer of Roblox, a game platform, which was released in 2006. As of December 31, 2024, the company employs over 2,400 people.

DXCM vs RBLX — Head-to-Head

Bigger by revenue
RBLX
RBLX
1.1× larger
RBLX
$1.4B
$1.3B
DXCM
Growing faster (revenue YoY)
RBLX
RBLX
+21.6% gap
RBLX
43.2%
21.6%
DXCM
Higher net margin
DXCM
DXCM
43.6% more per $
DXCM
21.2%
-22.3%
RBLX
Faster 2-yr revenue CAGR
RBLX
RBLX
Annualised
RBLX
32.9%
12.0%
DXCM

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
DXCM
DXCM
RBLX
RBLX
Revenue
$1.3B
$1.4B
Net Profit
$267.3M
$-316.0M
Gross Margin
62.9%
77.7%
Operating Margin
25.6%
-25.3%
Net Margin
21.2%
-22.3%
Revenue YoY
21.6%
43.2%
Net Profit YoY
153.6%
-43.9%
EPS (diluted)
$0.67
$-0.44

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DXCM
DXCM
RBLX
RBLX
Q1 26
$1.3B
Q4 25
$1.3B
$1.4B
Q3 25
$1.2B
$1.4B
Q2 25
$1.2B
$1.1B
Q1 25
$1.0B
$1.0B
Q4 24
$1.1B
$988.2M
Q3 24
$994.2M
$919.0M
Q2 24
$1.0B
$893.5M
Net Profit
DXCM
DXCM
RBLX
RBLX
Q1 26
$267.3M
Q4 25
$267.3M
$-316.0M
Q3 25
$283.8M
$-255.6M
Q2 25
$179.8M
$-278.4M
Q1 25
$105.4M
$-215.1M
Q4 24
$151.7M
$-219.6M
Q3 24
$134.6M
$-239.3M
Q2 24
$143.5M
$-205.9M
Gross Margin
DXCM
DXCM
RBLX
RBLX
Q1 26
62.9%
Q4 25
62.9%
77.7%
Q3 25
60.5%
78.2%
Q2 25
59.5%
78.2%
Q1 25
56.9%
78.3%
Q4 24
58.9%
77.9%
Q3 24
59.7%
77.7%
Q2 24
62.4%
77.8%
Operating Margin
DXCM
DXCM
RBLX
RBLX
Q1 26
25.6%
Q4 25
25.6%
-25.3%
Q3 25
20.1%
-21.8%
Q2 25
18.4%
-29.8%
Q1 25
12.9%
-24.6%
Q4 24
17.0%
-24.7%
Q3 24
15.3%
-30.4%
Q2 24
15.7%
-26.6%
Net Margin
DXCM
DXCM
RBLX
RBLX
Q1 26
21.2%
Q4 25
21.2%
-22.3%
Q3 25
23.5%
-18.8%
Q2 25
15.5%
-25.8%
Q1 25
10.2%
-20.8%
Q4 24
13.6%
-22.2%
Q3 24
13.5%
-26.0%
Q2 24
14.3%
-23.0%
EPS (diluted)
DXCM
DXCM
RBLX
RBLX
Q1 26
$0.67
Q4 25
$0.67
$-0.44
Q3 25
$0.70
$-0.37
Q2 25
$0.45
$-0.41
Q1 25
$0.27
$-0.32
Q4 24
$0.37
$-0.32
Q3 24
$0.34
$-0.37
Q2 24
$0.35
$-0.32

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DXCM
DXCM
RBLX
RBLX
Cash + ST InvestmentsLiquidity on hand
$917.7M
$3.1B
Total DebtLower is stronger
$1.2B
Stockholders' EquityBook value
$2.7B
$394.5M
Total Assets
$6.3B
$9.6B
Debt / EquityLower = less leverage
2.98×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DXCM
DXCM
RBLX
RBLX
Q1 26
$917.7M
Q4 25
$917.7M
$3.1B
Q3 25
$1.8B
$2.9B
Q2 25
$1.2B
$2.6B
Q1 25
$904.9M
$2.7B
Q4 24
$606.1M
$2.4B
Q3 24
$621.2M
$2.3B
Q2 24
$939.2M
$2.4B
Total Debt
DXCM
DXCM
RBLX
RBLX
Q1 26
Q4 25
$1.2B
Q3 25
Q2 25
Q1 25
Q4 24
$1.2B
Q3 24
Q2 24
Stockholders' Equity
DXCM
DXCM
RBLX
RBLX
Q1 26
$2.7B
Q4 25
$2.7B
$394.5M
Q3 25
$2.7B
$407.6M
Q2 25
$2.6B
$353.2M
Q1 25
$2.3B
$310.7M
Q4 24
$2.1B
$221.4M
Q3 24
$2.0B
$189.9M
Q2 24
$2.4B
$121.5M
Total Assets
DXCM
DXCM
RBLX
RBLX
Q1 26
$6.3B
Q4 25
$6.3B
$9.6B
Q3 25
$7.5B
$8.6B
Q2 25
$7.3B
$7.8B
Q1 25
$6.8B
$7.5B
Q4 24
$6.5B
$7.2B
Q3 24
$6.4B
$6.7B
Q2 24
$6.8B
$6.5B
Debt / Equity
DXCM
DXCM
RBLX
RBLX
Q1 26
Q4 25
2.98×
Q3 25
Q2 25
Q1 25
Q4 24
5.48×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DXCM
DXCM
RBLX
RBLX
Operating Cash FlowLast quarter
$607.0M
Free Cash FlowOCF − Capex
$308.6M
FCF MarginFCF / Revenue
21.8%
Capex IntensityCapex / Revenue
21.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$1.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DXCM
DXCM
RBLX
RBLX
Q1 26
Q4 25
$294.0M
$607.0M
Q3 25
$659.9M
$546.2M
Q2 25
$303.0M
$199.3M
Q1 25
$183.8M
$443.9M
Q4 24
$301.4M
$184.5M
Q3 24
$199.5M
$247.4M
Q2 24
$279.4M
$151.4M
Free Cash Flow
DXCM
DXCM
RBLX
RBLX
Q1 26
Q4 25
$192.1M
$308.6M
Q3 25
$579.4M
$443.6M
Q2 25
$208.9M
$176.7M
Q1 25
$96.8M
$426.5M
Q4 24
$176.8M
$120.6M
Q3 24
$88.3M
$218.0M
Q2 24
$213.3M
$111.7M
FCF Margin
DXCM
DXCM
RBLX
RBLX
Q1 26
Q4 25
15.3%
21.8%
Q3 25
47.9%
32.6%
Q2 25
18.1%
16.3%
Q1 25
9.3%
41.2%
Q4 24
15.9%
12.2%
Q3 24
8.9%
23.7%
Q2 24
21.2%
12.5%
Capex Intensity
DXCM
DXCM
RBLX
RBLX
Q1 26
Q4 25
8.1%
21.1%
Q3 25
6.7%
7.5%
Q2 25
8.1%
2.1%
Q1 25
8.4%
1.7%
Q4 24
11.2%
6.5%
Q3 24
11.2%
3.2%
Q2 24
6.6%
4.4%
Cash Conversion
DXCM
DXCM
RBLX
RBLX
Q1 26
Q4 25
1.10×
Q3 25
2.33×
Q2 25
1.69×
Q1 25
1.74×
Q4 24
1.99×
Q3 24
1.48×
Q2 24
1.95×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons